GlassScriptPhysician profile
Michael A Scutella
NPI 1487606554
$1,141.19
in general payments reported to CMS, 2019-2025
31 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.69 · 2020: $24.74 · 2021: $114 · 2022: $212 · 2023: $237 · 2024: $292 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $733.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genmab U.S., INC. | $124.74 | 2022 | |
| Hologic Sales and Service, LLC | $124.65 | 2021-2024 | Thinprep 2000 Processor, Aptima |
| Caldera Medical, INC | $88.63 | 2025 | |
| Siemens Medical Solutions USA, INC. | $88.43 | 2021 | |
| Smith+Nephew, INC. | $85.52 | 2023-2024 | Stravix, Grafix Pl, Stravix Pl |
| Astellas Pharma US INC | $83.75 | 2022-2024 | Veozah |
| Abbvie INC. | $83.33 | 2023-2025 | Lo Loestrin Fe |
| Organon LLC | $62.20 | 2023-2024 | Nexplanon |
| Sage Therapeutics, LLC | $49.89 | 2024 | |
| Pfizer INC. | $39.40 | 2022-2025 | |
| Exact Sciences Corporation | $37.29 | 2024-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $35.07 | 2019-2025 | |
| Exeltis, USA INC. | $28.30 | 2023 | Slynd |
| Allergan, INC. | $26.44 | 2019-2021 | |
| Amgen INC. | $26.05 | 2020-2025 | Evenity |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $25.64 | 2023 | Arexvy |
| Hologic INC | $22.38 | 2022 | |
| Shield Therapeutics INC | $20.71 | 2024 | |
| Roche Diagnostics Corporation | $17.99 | 2019 | |
| Corcept Therapeutics | $16.56 | 2025 | Korlym |
| Axonics, INC. | $15.67 | 2022 | |
| Covidien LP | $12.93 | 2020 | |
| Conmed Corporation | $12.90 | 2022 | |
| Daiichi Sankyo INC. | $12.72 | 2019 |
7 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Scutella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.